Sponsors (9)
The bill helps improve patient care and antibiotic stewardship by enabling and incentivizing penicillin-allergy verification (including Medicare coverage), but it requires upfront spending, administrative work, and risks uneven access and short-term costs for some patients and health systems.
Hospitals and patients: verifying and removing incorrect penicillin-allergy labels reduces hospital length-of-stay, lowers perioperative and other antibiotic-related infections, and supports antibiotic stewardship to slow resistance.
Medicare beneficiaries: allowing verification during the initial preventive physical or annual wellness visit (and clarifying coverage) expands access and encourages clinicians to reassess inaccurate penicillin-allergy labels.
Health systems and taxpayers: penicillin-allergy evaluation can be cost-saving over time by enabling use of cheaper, first-line antibiotics and reducing complications from inappropriate broad-spectrum use.
Hospitals, health systems, and taxpayers: implementing verification programs requires upfront costs for testing, training, staffing and workflows and could increase short-term Medicare spending for additional billable services.
Healthcare workers, providers, and government administrators: clinicians, Medicare administrators, and public-health bodies must allocate time and resources to update workflows, billing systems, and run delabeling programs, creating administrative and operational burden that may divert attention from other priorities.
Rural, low-income, and under-resourced patients: access disparities mean some people may lack timely or local access to verification services, so benefits may be unevenly distributed.
Based on analysis of 3 sections of legislative text.
Makes penicillin allergy verification and evaluation a covered service during Medicare initial preventive physical exams and annual wellness visits, with defined scope and referrals.
Introduced October 10, 2025 by H. Morgan Griffith · Last progress October 10, 2025
Adds coverage for penicillin allergy verification and evaluation to Medicare’s initial preventive physical exam and annual wellness visit, defining the service to include identifying people who report a penicillin allergy, assessing whether the report reflects a true allergy, providing information about health and public-health impacts of the allergy label, and referring patients to allergy specialists as appropriate. The change allows separate payment for structured penicillin-allergy validation services done the same day and takes effect for services furnished on or after January 1, 2027.